Vasopressin-Resistant Nephrogenic Diabetes Insipidus: A Result of Amphotericin B Therapy

Archives of Internal Medicine

Volumn 139, Issue 1, 1979, Pages 86-88

  Barbour, Galen L ^a   Straub, Karl D ^a   O'neal, Barry L ^a   Leatherman, James W ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; LITHIUM CARBONATE; PF1 LITHIUM; UNCLASSIFIED DRUG; VASOPRESSIN;

ADVERSE DRUG REACTION; CASE REPORT; DIAGNOSIS; ETIOLOGY; KIDNEY; KIDNEY TUBULE DISORDER; NEPHROGENIC DIABETES INSIPIDUS; NEPHROTOXICITY; THERAPY;

AMPHOTERICIN B; CASE REPORT; DIABETES INSIPIDUS; HUMAN; KIDNEY CONCENTRATING ABILITY; KIDNEY DISEASES; MALE; MIDDLE AGE; OSMOLAR CONCENTRATION; URINE; VASOPRESSINS; WATER DEPRIVATION;

EID: 0018566219     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1979.03630380064021     Document Type: Article

References (20)

1. Patterson RM, Ackerman GA: Renal tubular acidosis due to amphotericin B nephrotoxicity. Arch Intern Med 127:241-244, 1971.
2. Butler WT, Gennett JE, Ailing DW, et al: Nephrotoxicity of amphotericin B: Early and late effects in 81 patients. Ann Intern Med 61:175-187, 1964.
3. Burgess JL, Birchall R: Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. Am J Med 53:77-84, 1972.
4. Bell NH, Andriole VT, Sabesin SM, et al: On the nephrotoxicity of amphotericin B in man. Am J Med 33:64-69, 1962.
5. Beard HW, Richert JH, Taylor RR: The treatment of deep mycotic infections with amphotericin B. Am Rev Respir Dis 81:43-51, 1960.
6. Holgman CW, Einstein H: The toxic effects of amphotericin B in man. Calif Med 99:90-93, 1963.
7. Douglas JB, Healy JK: Nephrotoxic effects of amphotericin B including renal tubular acidosis. Am J Med 46:154-162, 1969.
8. Singer I, Rotenberg D: Demeclocycline-induced nephrogenic diabetes insipidus: In-vivo and in-vitro studies. Ann Intern Med 79:679-683, 1973.
9. Chaimovitz C, Levi J, Better OS, et al: Studies on the site of renal salt loss in a patient with Bartter's syndrome. Pediatr Res 7:89-94, 1973.
10. Gouge TH, Andriole VT: An experimental model of amphotericin B nephrotoxicity with renal tubular acidosis. J Lab Clin Med 73:713-724, 1971.
11. Bullock WE, Luke RG, Nuttall CE, et al: Can mannitol reduce amphotericin B nephrotoxicity? Antimicrob Agents Chemother 10:555-563, 1976.
12. Gottschalk CW: Osmotic concentration and dilution of urine. Am J Med 36:670-685, 1964.
13. Cass A, Finklestein A, Krespi V: The ion permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B. J Gen Physiol 56:100-124, 1970.
14. Utz JP: Amphotericin B toxicity: General side effects. Ann Intern Med 61:340-343, 1964.
15. Singer I, Forrest JN Jr: Drug-induced states of nephrogenic diabetes insipidus. Kidney Int 10:82-95, 1976.
16. Berl T, Anderson RJ, McDonald KM, et al: Clinical disorders of water metabolism. Kidney Int 10:117-132, 1976.
17. Deutsch S: Effects of anesthetics on the kidney. Surg Clin North Am 55:775-786, 1975.
18. Singer I, Rotenberg D, Puschett JB: Lithium-induced nephrogenic diabetes insipidus: In-vivo and in-vitro studies. J Clin Invest 51:1081-1091, 1972.
19. Epstein FH: Calcium nephropathy, in Strauss MB, Welt LG (eds): Diseases of the Kidney. Boston, Little Brown & Co, 1971, p 913.
20. Hollander W, Blythe WB: Nephropathy of potassium depletion, in Strauss MB, Welt LG (eds): Diseases of the Kidney. Boston, Little Brown & Co, 1971, p 954.